July 24, 2016 1:31 AM ET

Life Sciences Tools and Services

Company Overview of The EMMES Corporation

Company Overview

The EMMES Corporation operates as a contract research organization. Its products include EMMES AdvantageEDC, a platform that provides study design tools and data collection in electronic case report forms and data quality management; EMMES RTS, a platform to assist in coordination, collection, organization, and retrieval of regulatory documentation for investigational sites; and EMMES GlobalTrace, a materials/specimen management platform that tracks in real-time from collection at a clinical site to arrival and storage at a central laboratory or repository. The company’s services include statistical leadership and project management, study design and protocol development, Web-based data coll...

401 North Washington Street

Suite 700

Rockville, MD 20850

United States

Founded in 1977

Phone:

301-251-1161

Fax:

301-251-1355

Key Executives for The EMMES Corporation

Chief Executive Officer and President
Chief Financial Officer and Vice President
Chief Operating Officer
Chief Medical Officer
Vice President
Compensation as of Fiscal Year 2016.

The EMMES Corporation Key Developments

Emmes Corp. Appoints Paul Vanveldhuisen as Chief Operating Officer

Emmes Corp. announced that it has appointed Paul VanVeldhuisen as chief operating officer.

The Emmes Corporation Promotes Paul Vanveldhuisen as Chief Operating Officer

The Emmes Corporation announced that Dr. Paul VanVeldhuisen has been promoted to the newly created position of chief operating officer. Dr. VanVeldhuisen, who started at Emmes as a statistician and epidemiologist, will assume the additional leadership responsibilities while continuing to serve as principal investigator for government and privately funded research projects. Dr. VanVeldhuisen joined the company in 1993 and was promoted to vice president in 2006. He is responsible for the scientific aspects of various research studies, including study design and analysis, and he oversees day-to-day operations of clinical trial support. Dr. VanVeldhuisen has contributed to research in important public health areas, including ophthalmology, drug abuse, organ transplantation and infectious disease.

EMMES Corp. Wins $7.93 Million Federal Contract

EMMES Corp. won a federal contract from the U.S. Department of Health and Human Services' National Institutes of Health, Bethesda, Maryland, for research and development services. The agency said the contract had the following value: $7,929,947 plus six one-year term options (worth $53,415,968 total) plus quantity options to increase level-of-effort (worth $29,876,760 total) plus one a non-severable transition option (worth $2,345,909).

Similar Private Companies By Industry

Company Name Region
10X Genomics, Inc. United States
4G Clinical, Inc. United States
AAPharmaSyn LLC United States
Abiant, Inc. United States
aBioBot, Inc. United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Bloomberg L.P. United States
NYC2012, Inc. United States
Rush University United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact The EMMES Corporation, please visit www.emmes.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.